232 related articles for article (PubMed ID: 35955755)
21. Cytochrome P450 expression, induction and activity in human induced pluripotent stem cell-derived intestinal organoids and comparison with primary human intestinal epithelial cells and Caco-2 cells.
Janssen AWF; Duivenvoorde LPM; Rijkers D; Nijssen R; Peijnenburg AACM; van der Zande M; Louisse J
Arch Toxicol; 2021 Mar; 95(3):907-922. PubMed ID: 33263786
[TBL] [Abstract][Full Text] [Related]
22. Generation of small intestinal organoids for experimental intestinal physiology.
Capeling M; Huang S; Mulero-Russe A; Cieza R; Tsai YH; Garcia A; Hill DR
Methods Cell Biol; 2020; 159():143-174. PubMed ID: 32586441
[TBL] [Abstract][Full Text] [Related]
23.
Tsai YH; Nattiv R; Dedhia PH; Nagy MS; Chin AM; Thomson M; Klein OD; Spence JR
Development; 2017 Mar; 144(6):1045-1055. PubMed ID: 27927684
[TBL] [Abstract][Full Text] [Related]
24. Aggregation of cryopreserved mid-hindgut endoderm for more reliable and reproducible hPSC-derived small intestinal organoid generation.
Pitstick AL; Poling HM; Sundaram N; Lewis PL; Kechele DO; Sanchez JG; Scott MA; Broda TR; Helmrath MA; Wells JM; Mayhew CN
Stem Cell Reports; 2022 Aug; 17(8):1889-1902. PubMed ID: 35905739
[TBL] [Abstract][Full Text] [Related]
25. Using Bioengineered Fluorescence for Selective In Vivo and Ex Vivo Tracking of Intestinal Organoids Derived from Human Pluripotent Stem Cells.
Lee H; Son MY
Methods Mol Biol; 2020; 2126():57-71. PubMed ID: 32112379
[TBL] [Abstract][Full Text] [Related]
26. Human intestinal organoids express histo-blood group antigens, bind norovirus VLPs, and support limited norovirus replication.
Zhang D; Tan M; Zhong W; Xia M; Huang P; Jiang X
Sci Rep; 2017 Oct; 7(1):12621. PubMed ID: 28974702
[TBL] [Abstract][Full Text] [Related]
27. Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells.
Estrada HQ; Patel S; Rabizadeh S; Casero D; Targan SR; Barrett RJ
Inflamm Bowel Dis; 2022 May; 28(5):667-679. PubMed ID: 34918082
[TBL] [Abstract][Full Text] [Related]
28. Blockade of STAT3 Causes Severe In Vitro and In Vivo Maturation Defects in Intestinal Organoids Derived from Human Embryonic Stem Cells.
Jung KB; Kwon O; Lee MO; Lee H; Son YS; Habib O; Oh JH; Cho HS; Jung CR; Kim J; Son MY
J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31277507
[TBL] [Abstract][Full Text] [Related]
29. Modeling Intestinal Epithelial Response to Interferon-γ in Induced Pluripotent Stem Cell-Derived Human Intestinal Organoids.
Workman MJ; Troisi E; Targan SR; Svendsen CN; Barrett RJ
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396621
[TBL] [Abstract][Full Text] [Related]
30. Engineered Synthetic Matrices for Human Intestinal Organoid Culture and Therapeutic Delivery.
Mulero-Russe A; García AJ
Adv Mater; 2024 Mar; 36(9):e2307678. PubMed ID: 37987171
[TBL] [Abstract][Full Text] [Related]
31. An in vivo model of human small intestine using pluripotent stem cells.
Watson CL; Mahe MM; Múnera J; Howell JC; Sundaram N; Poling HM; Schweitzer JI; Vallance JE; Mayhew CN; Sun Y; Grabowski G; Finkbeiner SR; Spence JR; Shroyer NF; Wells JM; Helmrath MA
Nat Med; 2014 Nov; 20(11):1310-4. PubMed ID: 25326803
[TBL] [Abstract][Full Text] [Related]
32.
Lee H; Jung KB; Kwon O; Son YS; Choi E; Yu WD; Son N; Jeon JH; Jo H; Yang H; Son YR; Yun CS; Cho HS; Kim SK; Kim DS; Park DS; Son MY
Gut Microbes; 2022; 14(1):2121580. PubMed ID: 36130031
[TBL] [Abstract][Full Text] [Related]
33. Retinoic acid promotes barrier functions in human iPSC-derived intestinal epithelial monolayers.
Yamada S; Kanda Y
J Pharmacol Sci; 2019 Aug; 140(4):337-344. PubMed ID: 31399314
[TBL] [Abstract][Full Text] [Related]
34. Generating human intestinal tissues from pluripotent stem cells to study development and disease.
Sinagoga KL; Wells JM
EMBO J; 2015 May; 34(9):1149-63. PubMed ID: 25792515
[TBL] [Abstract][Full Text] [Related]
35. Human intestinal organoid-derived PDGFRα + mesenchymal stroma enables proliferation and maintenance of LGR4 + epithelial stem cells.
Chen J; Horiuchi S; Kuramochi S; Kawasaki T; Kawasumi H; Akiyama S; Arai T; Morinaga K; Kimura T; Kiyono T; Akutsu H; Ishida S; Umezawa A
Stem Cell Res Ther; 2024 Jan; 15(1):16. PubMed ID: 38229108
[TBL] [Abstract][Full Text] [Related]
36. Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells.
Mithal A; Capilla A; Heinze D; Berical A; Villacorta-Martin C; Vedaie M; Jacob A; Abo K; Szymaniak A; Peasley M; Stuffer A; Mahoney J; Kotton DN; Hawkins F; Mostoslavsky G
Nat Commun; 2020 Jan; 11(1):215. PubMed ID: 31924806
[TBL] [Abstract][Full Text] [Related]
37. Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells.
Son MY; Sim H; Son YS; Jung KB; Lee MO; Oh JH; Chung SK; Jung CR; Kim J
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):584-603. PubMed ID: 28235153
[TBL] [Abstract][Full Text] [Related]
38. Protocol to generate large human intestinal organoids using a rotating bioreactor.
Takahashi J; Sugihara HY; Kato S; Nagata S; Okamoto R; Mizutani T
STAR Protoc; 2023 Sep; 4(3):102374. PubMed ID: 37352105
[TBL] [Abstract][Full Text] [Related]
39. Suspension culture promotes serosal mesothelial development in human intestinal organoids.
Capeling MM; Huang S; Childs CJ; Wu JH; Tsai YH; Wu A; Garg N; Holloway EM; Sundaram N; Bouffi C; Helmrath M; Spence JR
Cell Rep; 2022 Feb; 38(7):110379. PubMed ID: 35172130
[TBL] [Abstract][Full Text] [Related]
40. Building additional complexity to in vitro-derived intestinal tissues.
Brugmann SA; Wells JM
Stem Cell Res Ther; 2013; 4 Suppl 1(Suppl 1):S1. PubMed ID: 24565179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
